From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume 37, Issue 1, Pages 4-15
Publisher
Springer Nature
Online
2011-09-28
DOI
10.1038/npp.2011.181
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical profile of a novel metabotropic glutamate receptor 5 positive allosteric modulator
- (2011) Nathan Spear et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia
- (2011) Bruce J. Kinon et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- NR3A-containing NMDARs promote neurotransmitter release and spike timing–dependent plasticity
- (2011) Rylan S Larsen et al. NATURE NEUROSCIENCE
- Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice
- (2010) Karla Kopec et al. BIOCHEMICAL PHARMACOLOGY
- Mutant Mice and Rats Lacking D-Amino Acid Oxidase
- (2010) Ryuichi Konno et al. CHEMISTRY & BIODIVERSITY
- Pregnenolone, Dehydroepiandrosterone, and Schizophrenia: Alterations and Clinical Trials
- (2010) Michael S. Ritsner CNS Neuroscience & Therapeutics
- Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
- (2010) Guochuan Tsai et al. CURRENT PHARMACEUTICAL DESIGN
- Recent Progress in the Discovery of Non-Sarcosine Based GlyT1 Inhibitors
- (2010) Scott Wolkenberg et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The antipsychotic potential of muscarinic allosteric modulation
- (2010) T.M. Bridges et al. DRUG NEWS & PERSPECTIVES
- Schizophrenia: The drug deadlock
- (2010) Alison Abbott NATURE
- A Possible Role for the Striatum in the Pathogenesis of the Cognitive Symptoms of Schizophrenia
- (2010) Eleanor H. Simpson et al. NEURON
- Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning
- (2010) Tyler A Lesh et al. NEUROPSYCHOPHARMACOLOGY
- d-Serine and a glycine transporter-1 inhibitor enhance social memory in rats
- (2010) Toshiharu Shimazaki et al. PSYCHOPHARMACOLOGY
- Cortical Kynurenine Pathway Metabolism: A Novel Target for Cognitive Enhancement in Schizophrenia
- (2010) I. Wonodi et al. SCHIZOPHRENIA BULLETIN
- Validating Novel Targets for Pharmacological Interventions in Schizophrenia
- (2009) Barbara Wroblewska et al. AMERICAN JOURNAL OF PSYCHIATRY
- When Doors of Perception Close: Bottom-up Models of Disrupted Cognition in Schizophrenia
- (2009) Daniel C. Javitt Annual Review of Clinical Psychology
- Co-Administration of a D-Amino Acid Oxidase Inhibitor Potentiates the Efficacy of D-Serine in Attenuating Prepulse Inhibition Deficits After Administration of Dizocilpine
- (2009) Kenji Hashimoto et al. BIOLOGICAL PSYCHIATRY
- A randomized, double-blind, placebo-controlled comparison study of sarcosine ( N-methylglycine) and d-serine add-on treatment for schizophrenia
- (2009) Hsien-Yuan Lane et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Glutamatergic (N-Methyl-D-aspartate Receptor) Hypofrontality in Schizophrenia: Too Little Juice or a Miswired Brain?
- (2009) G. J. Marek et al. MOLECULAR PHARMACOLOGY
- Association of common copy number variants at the glutathione S-transferase genes and rare novel genomic changes with schizophrenia
- (2009) B Rodríguez-Santiago et al. MOLECULAR PSYCHIATRY
- Glutaminase-Deficient Mice Display Hippocampal Hypoactivity, Insensitivity to Pro-Psychotic Drugs and Potentiated Latent Inhibition: Relevance to Schizophrenia
- (2009) Inna Gaisler-Salomon et al. NEUROPSYCHOPHARMACOLOGY
- Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia
- (2009) Christine E Marx et al. NEUROPSYCHOPHARMACOLOGY
- The involvement of the NMDA receptor d-serine/glycine site in the pathophysiology and treatment of schizophrenia
- (2009) Viviane Labrie et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Norbin Is an Endogenous Regulator of Metabotropic Glutamate Receptor 5 Signaling
- (2009) H. Wang et al. SCIENCE
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- Effects of an NMDA-receptor antagonist MK-801 on an MMN-like response recorded in anesthetized rats
- (2008) Dmitry Tikhonravov et al. BRAIN RESEARCH
- N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility
- (2008) Seetal Dodd et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Central auditory dysfunction in schizophrenia as revealed by the mismatch negativity (MMN) and its magnetic equivalent MMNm: a review
- (2008) Risto Näätänen et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
- (2008) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Deviance-elicited Changes in Event-related Potentials are Attenuated by Ketamine in Mice
- (2008) Richard S. Ehrlichman et al. JOURNAL OF COGNITIVE NEUROSCIENCE
- ADX47273 [S-(4-Fluoro-phenyl)- -methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-Like and Procognitive Activities
- (2008) F. Liu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database
- (2008) Nicole C Allen et al. NATURE GENETICS
- Presynaptic NMDA Receptors: Newly Appreciated Roles in Cortical Synaptic Function and Plasticity
- (2008) Rebekah Corlew et al. NEUROSCIENTIST
- Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis
- (2008) Karsten Heekeren et al. PSYCHOPHARMACOLOGY
- Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia
- (2008) P. Jeffrey Conn et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Sarcosine (N-Methylglycine) Treatment for Acute Schizophrenia: A Randomized, Double-Blind Study
- (2007) Hsien-Yuan Lane et al. BIOLOGICAL PSYCHIATRY
- Subtle Cognitive Dysfunction in Nonaffected Siblings of Individuals Affected by Nonpsychotic Disorders
- (2007) Mark Weiser et al. BIOLOGICAL PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search